Skip to main content

Incyte Q3 FY2026 results

  • INCY · Nasdaq
  • Biotechnology
  • S&P 500
$120.97−0.60%Close 13 Nov 2026 · Market value $24.66B

Incyte reported revenue of $1.56 billion, up 14.0% from a year earlier, net income of −$785 million and diluted earnings per share of −$3.86 against $2.11 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, filed 29 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Incyte Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$1.56B$1.37B+14.0%
Gross profit$1.45B$1.27B+14.3%
Gross margin93.0%92.8%+0.3 pts
Operating income−$708.4M$443.5M—
Operating margin−45.5%32.5%−78.0 pts
Net income−$784.8M$424.2M—
Diluted EPS−$3.86$2.11—
Operating cash flow−$675.3M$559.4M—
Capital expenditure$15.63M$14.75M+6.0%
Free cash flow−$691.0M$544.6M—

Operating KPIs for the quarter

Incyte operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Customer A (change on a year)10%down 4.0 points
JAKAFI revenue$826.5Mup 4.5%
OPZELURA revenue$254.9Mup 35.6%
Product royalty revenues$191.0Mup 11.6%
JAKAVI revenue$132.5Mup 5.4%
NIKTIMVO revenue$67.4Mup 47.0%
ZYNYZ revenue$58.3Mup 157.2%
MINJUVI/MONJUVI revenue$54.6Mup 30.1%
Milestone and contract revenues$49.8Mup 10.7%
OLUMIANT revenue$39.1Mup 5.2%
ICLUSIG revenue$33.5Mdown 10.8%
PEMAZYRE revenue$21.2Mdown 6.9%
TABRECTA revenue$6.8Mup 4.9%
United States revenue$1.4Bup 13.8%
Europe revenue$107.4Mup 7.0%

Earlier quarters

Incyte results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$1.56B+14.0%−$3.86
Q2 FY202630 Jun 2026$1.67B+37.7%$2.81
Q1 FY202631 Mar 2026$1.27B+20.9%$1.47
Q4 FY202531 Dec 2025$1.51B+27.8%$1.46
Q3 FY202530 Sep 2025$1.37B+20.0%$2.11
Q2 FY202530 Jun 2025$1.22B+16.5%$2.04
Q1 FY202531 Mar 2025$1.05B+19.5%$0.80
Q4 FY202431 Dec 2024$1.18B+16.3%$0.97

More on Incyte: financial statements · revenue · earnings per share

INCY's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.